NDT Pharmaceuticals Inc. is a Canada-based biotechnology company. The Company is focused on developing nutraceutical and pharmaceutical products. The Company’s nanoscale particle complex (NPC) technology represents the edge of phospholipid-based nano-encapsulation delivery systems, which is approximately 100 nanometers in diameter; mean diameter of approximately 40 nanometers in liquid product samples with the capability to engineer significantly smaller nanocarrier particles, which creates delivery of payloads into the bloodstream, beginning through the membranes of the mouth. The NPC technology also incorporates an ingredient, which stimulates repair of damaged cell tissue, Cell Armor.